SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-083521
Filing Date
2024-09-30
Accepted
2024-09-30 19:11:04
Documents
1
Period of Report
2024-09-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3484
  Complete submission text file 0001213900-24-083521.txt   5103
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Issuer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address
Ramdeen Timothy R. (Reporting) CIK: 0001962363 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41294 | Film No.: 241340878